NCT07417059 Sex Hormones Impact on Cannabis Response
| NCT ID | NCT07417059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University |
| Condition | Cannabis |
| Study Type | INTERVENTIONAL |
| Enrollment | 21 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 21 participants in total. It began in 2025-06-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to systematically determine whether the cannabis response in human females is related to SH fluctuations throughout the menstrual cycle.
Eligibility Criteria
Inclusion Criteria: * Biological female * Used cannabis between 1 time a month and 2 times a week during the previous year * Age between 18 and 40 years * Free from psychotropic medication * Free from hormonal birth control * A regular menstrual cycle (last 3 cycles a duration between 21 and 35 days). * Good physical health as determined by medical examination and laboratory analysis * Absence of any major medical, endocrine and neurological condition as determined by medical examination and laboratory analysis * Normal weight, body mass index (weight/height2) between 18 and 28 kg/m2 * Written Informed Consent * Good knowledge and understanding of the English language * Participants must be willing to refrain from taking illicit psychoactive substances during the study. * Participants must be willing to drink only alcohol-free liquids and no coffee, black or green tea, or energy drinks after midnight of the evening before the study session, as well as during the study day. * Participants must be willing not to drive a traffic vehicle or to operate machines within 24 h after substance administration. Exclusion Criteria: * History of drug addiction (determined by the medical questionnaire, drug questionnaire and medical examination) * Pregnancy or lactation or pregnancy planned during study participation * Hypertension (diastolic \> 90 mmHg; systolic \> 140 mmHg) * Current or history of psychiatric disorder (determined by the medical questionnaire and medical examination) * Current presence or history of psychosis in first-degree relatives * Any chronic or acute medical condition * History of cardiac dysfunctions (arrhythmia, ischemic heart disease,…) * Tobacco smoking (\>20 per day) * Excessive drinking (\>20 alcoholic consumptions per week)
Frequently Asked Questions
Who can join the NCT07417059 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Cannabis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07417059 currently recruiting?
Yes, NCT07417059 is actively recruiting participants. Visit ClinicalTrials.gov or contact Maastricht University to inquire about joining.
Where is the NCT07417059 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT07417059 clinical trial?
NCT07417059 is sponsored by Maastricht University. The trial plans to enroll 21 participants.